Mednax Inc (MD) Receives a Hold from Stifel Nicolaus


In a report issued on November 1, Chad Vanacore from Stifel Nicolaus reiterated a Hold rating on Mednax Inc (MD), with a price target of $44. The company’s shares opened today at $38.78, close to its 52-week low of $37.26.

According to TipRanks.com, Vanacore is a 3-star analyst with an average return of 1.4% and a 57.4% success rate. Vanacore covers the Financial sector, focusing on stocks such as National Health Investors, Medical Properties, and Omega Healthcare.

Currently, the analyst consensus on Mednax Inc is a Moderate Buy with an average price target of $46.67, implying a 20.3% upside from current levels. In a report issued on October 19, Robert W. Baird also maintained a Hold rating on the stock with a $48 price target.

.

See today’s analyst top recommended stocks >>

Mednax Inc’s market cap is currently $3.5B and has a P/E ratio of 10.56. The company has a Price to Book ratio of 1.16.

Based on the recent corporate insider activity of 35 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company’s solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts